Effects of glucagon-like peptide-1 receptor agonists combined with exercise, versus exercise alone, on body composition and anthropometric measures of weight loss: A systematic review and meta-analysis of randomized clinical trials
Advanced Exercise and Health Science · 2026-11
DOI: 10.1016/j.aehs.2026.09.003 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Advanced Exercise and Health Science, 2026-11. Verfasst von Gustavo Stocker und 9 weiteren Autor:innen. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has demonstrated impressive weight loss, but their potential when combined with exercise requires further investigation regarding body composition and other anthropometric measures of weight loss. A systematic review and meta-analysis of randomized clinical trials (PROSPERO registration: CRD420251054056) was performed for the effects of GLP-1 RAs, combined or not with exercise, on body weight (BW), body mass index (BMI), body fat percentage (BFP), fat mass (FM), and fat-free mass (FFM). Three studies (260 participants) were included, ranging from 12 to 52 weeks. Compared with exercise alone, combined therapy reduced BW in the primary random-effects analysis (MD, −2.34 kg; 95% CI, −4.47 to −0.21; I² = 49.5%; P = 0.031; k = 3; n = 161), although this finding was not robust to Hartung–Knapp sensitivity analysis (95% CI, −7.52 to 2.84; P = 0.192). No clear differences were observed for BMI (MD, −0.47 kg/m²; 95% CI, −1.00 to 0.07; I² = 0%; P = 0.087; k = 2; n = 64), BFP (MD, −0.67 percentage points; 95% CI, −1.59 to 0.25; I² = 25.1%; P = 0.156; k = 3; n = 161), FM (MD, −1.44 kg; 95% CI, −4.96 to 2.09; I² = 74.4%; P = 0.424; k = 2; n = 128), or FFM (MD, −0.70 kg; 95% CI, −1.54 to 0.14; I² = 11.8%; P = 0.104; k = 3; n = 161). Certainty of the evidence was moderate for most outcomes and comparisons, but very low for FM versus exercise alone. In conclusion, combining GLP-1 RAs with exercise may provide additional BW reduction compared with exercise alone, but this finding was sensitive to the statistical method used. Current evidence does not demonstrate clear additional effects on BMI or body composition, and further adequately powered RCTs are needed.
Zitieren
APA
Stocker, G., Kazeminasab, F., Nejatkhah, F., Zarreh, M., Mirahmadi, N., Bagheri, R., Messenburger, G., Delpino, F. M., Kirwan, R., & Santos, H. O. (2026). Effects of glucagon-like peptide-1 receptor agonists combined with exercise, versus exercise alone, on body composition and anthropometric measures of weight loss: A systematic review and meta-analysis of randomized clinical trials. Advanced Exercise and Health Science. https://doi.org/10.1016/j.aehs.2026.09.003
Vancouver
Stocker G, Kazeminasab F, Nejatkhah F, Zarreh M, Mirahmadi N, Bagheri R, et al. Effects of glucagon-like peptide-1 receptor agonists combined with exercise, versus exercise alone, on body composition and anthropometric measures of weight loss: A systematic review and meta-analysis of randomized clinical trials. Advanced Exercise and Health Science. 2026. doi:10.1016/j.aehs.2026.09.003
BibTeX
@article{Stocker2026,
author = {Stocker, Gustavo and Kazeminasab, Fatemeh and Nejatkhah, Farzaneh and Zarreh, Mahdi and Mirahmadi, Navid and Bagheri, Reza and Messenburger, Gabriel and Delpino, Felipe M. and Kirwan, Richard and Santos, Heitor O.},
title = {Effects of glucagon-like peptide-1 receptor agonists combined with exercise, versus exercise alone, on body composition and anthropometric measures of weight loss: A systematic review and meta-analysis of randomized clinical trials},
journal = {Advanced Exercise and Health Science},
year = {2026},
doi = {10.1016/j.aehs.2026.09.003}
}
EUVIMED